Finance

Lists
Why is ARTV down 3.71%?
Dive Deeper
ARTV:NASDAQ
Artiva Biotherapeutics Inc
$ 7.00
-3.71%
(-0.27) 1D
$ 6.84
-2.29% (-0.16)
After hours
Closed: 10-р сарын 7, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
$ 7.10
High
$ 7.27
Low
$ 6.84
Mkt. cap
342.23 сая
Avg. vol.
449.74 мян
Volume
324.58 мян
52-wk high
$ 14.53
52-wk low
$ 2.71
EPS
-$ 3.31
Shares outstanding
48.89 сая
No. of employees
115
Open
$ 7.10
High
$ 7.27
Low
$ 6.84
Mkt. cap
342.23 сая
Avg. vol.
449.74 мян
Volume
324.58 мян
52-wk high
$ 14.53
52-wk low
$ 2.71
EPS
-$ 3.31
Shares outstanding
48.89 сая
No. of employees
115
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees115
Founded2019
Headquarters-
Sector-
Websiteartivabio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current $ 7.00
$ 41.00 (+485.71%)
Average
$ 38.00 (+442.86%)
Lowest
$ 35.00 (+400.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
$ 41.00
+485.7%
10/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$ 35.00
+400%
10/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$ 40.00
+471.4%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
$ 23.00
+228.6%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
$ 40.00
+471.4%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
$ 40.00
+471.4%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.63 сая
16.99 сая
19.31 сая
21.92 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.26 сая
4.94 сая
5.12 сая
4.96 сая
Operating expense
22.90 сая
21.93 сая
24.43 сая
26.89 сая
Total operating expenses
22.90 сая
21.93 сая
24.43 сая
26.89 сая
Operating income
-22.90 сая
-21.93 сая
-24.43 сая
-26.89 сая
Other non operating income
-3.00 мян
-1.88 сая
2.00 мян
-1.00 мян.
EBT including unusual items
-21.53 сая
-20.77 сая
-23.52 сая
-25.00 сая
EBT excluding unusual items
-21.53 сая
-22.65 сая
-23.52 сая
-25.00 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.53 сая
-20.77 сая
-23.52 сая
-25.00 сая
Net profit margin
-
-
-
-
Earnings per share
-0.88
-0.84
-0.95
-0.63
Interest and investment income
1.37 сая
1.16 сая
912.00 мян
1.89 сая
Interest expense
-
-
-
-
Net interest expenses
1.37 сая
1.16 сая
912.00 мян
1.89 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.24 сая
-21.27 сая
-23.76 сая
-26.20 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс